SIETES :: 93213 citas

Resultados de la búsqueda por INSOMNIO REFINAR BÚSQUEDA

1.

Anónimo. Melatonin for jet lag. Drug Ther Bull 2020;58:enero. [Ref.ID 103526]

2.

Cohen LS, Góez-Mogollón L, Sosinsky AZ, Savella GM, Viguera AC, Chitayat D, Hernández-Díaz S, Freeman MP. Risk of major malformations in infants following first-trimester exposure to quetiapine. Am J Psychiatry 2018:16 de agosto. [Ref.ID 102798]

3.

Anónimo. Femmes enceintes gênées par un mauvais sommeil. Prescrire 2018;38:354-60. [Ref.ID 102659]

4.

Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol 2017;73:927-35. [Ref.ID 101927]

5.

Lee TC, Desforges P, Downing N, Greene J, Ross JS. Off-label use of quetiapine in medical inpatients and postdischarge. JAMA Intern Med 2016;176:1390-1. [Ref.ID 100752]

6.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125-33. [Ref.ID 100634]

7.

Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med 2016;165:103-12. [Ref.ID 100633]

8.

Lee TC, Desforges P, Murray J, Saleh RR, McDonald EG. Off-label use of quetiapine in medical inpatients and postdischarge. JAMA Intern Med 2016:11 de julio. [Ref.ID 100488]

9.

Bradford AC, Bradford D. Medical marijuana laws reduce prescription medication use In Medicare Part D. Health Affairs 2016;37:julio. [Ref.ID 100483]

10.

Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010. Pharmacoepidemiol Drug Saf 2016;25:637-45. [Ref.ID 100393]

11.

Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA 2016;315:2230-2. [Ref.ID 100316]

12.

Herziq SJ, Rothberg MB, Guess JR, Stevens JP, Marshall J, Gurwitz JH, Marcantonio ER. Antipsychotic use in hospitalized adults: rates, indications, and predictors. J Am Geriatr Soc 2016;64:299-305. [Ref.ID 100051]

13.

Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics 2015;136:1144-53. [Ref.ID 99685]

14.

McCall C. Momentum grows for medical use of cannabis. Lancet 2015;386:1615-6. [Ref.ID 99633]

15.

Anónimo. Melatonin for sleep problems in children with neurodevelopmental disorders. Drug Ther Bull 2015;53:117-20. [Ref.ID 99604]

16.

Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015;175:1461-72. [Ref.ID 99522]

17.

Morin CM. Cognitive behavioral therapy for chronic insomnia: state of the science versus current clinical practices. Ann Intern Med 2015;163:236-7. [Ref.ID 99486]

18.

Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med 2015;163:191-204. [Ref.ID 99484]

19.

Anónimo. Drugs for insomnia. Med Lett Drugs Ther 2015;57:95-8. [Ref.ID 99452]

20.

Hawkes N. Modafinil does enhance cognition, review finds. BMJ 2015;351:h4573. [Ref.ID 99412]